CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating anastrozole or fulvestrant in postmenopausal patients with breast cancer has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institut Bergonié | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02